Steward Partners Investment Advisory
IMCR icon

Steward Partners Investment Advisory’s Immunocore IMCR Stock Holding History

Steward Partners Investment Advisory’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.17K Hold
100
– – ﹤0.01% 4120
2026
Q1 		$3.02K Hold
100
– – ﹤0.01% 3935
2025
Q4 		$3.47K Hold
100
– – ﹤0.01% 3813
2025
Q3 		$3.63K Hold
100
– – ﹤0.01% 3751
2025
Q2 		$3.14K Sell
100
-12
-11% -$373 ﹤0.01% 3620
2025
Q1 		$3.32K Hold
112
– – ﹤0.01% 3507
2024
Q4 		$3.3K Buy
112
+12
+12% +$379 ﹤0.01% 3490
2024
Q3 		$3.11K Hold
100
– – ﹤0.01% 3326
2024
Q2 		$3.39K Hold
100
– – ﹤0.01% 3155
2024
Q1 		$6.5K Hold
100
– – ﹤0.01% 2964
2023
Q4 		$6.83K Hold
100
– – ﹤0.01% 2851
2023
Q3 		$5.19K Hold
100
– – ﹤0.01% 2807
2023
Q2 		$6K Hold
100
– – ﹤0.01% 2736
2023
Q1 		$4.94K Hold
100
– – ﹤0.01% 2791
2022
Q4 		$5.71K Buy
+100
New +$5.63K ﹤0.01% 2727

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Steward Partners Investment Advisory's IMCR Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Immunocore (IMCR) position steady in Q2 2026 at 100 shares worth $3.17K. The position accounts for ﹤0.01% of the portfolio, ranked #4120.

Steward Partners Investment Advisory first reported a position in IMCR in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.83K in Q4 2023. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Steward Partners Investment Advisory held 100 shares of Immunocore worth $3.17K as of Q2 2026.
  • Steward Partners Investment Advisory left its Immunocore share count unchanged in Q2 2026.
  • Immunocore made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4120 holding.
  • Steward Partners Investment Advisory first reported a position in Immunocore in Q4 2022 and has held it in 15 quarters since.
  • Steward Partners Investment Advisory's Immunocore position peaked at $6.83K in Q4 2023.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.